Cargando…

Effect of Adjuvant Chemotherapy after Complete Resection for Pathologic Stage IB Lung Adenocarcinoma in High-Risk Patients as Defined by a New Recurrence Risk Scoring Model

PURPOSE: We conducted a retrospective analysis to determine if adjuvant chemotherapy prolongs overall survival in patients with pathologic stage IB lung adenocarcinoma who had undergone complete resection and were defined as high-risk by a newly developed recurrence risk scoring model. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Hyo Joon, Cho, Sukki, Kim, Kwhanmien, Jheon, Sanghoon, Yang, Hee Chul, Kim, Dong Kwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654174/ https://www.ncbi.nlm.nih.gov/pubmed/28111426 http://dx.doi.org/10.4143/crt.2016.312

Ejemplares similares

Frequency of Lymph Node Metastasis According to the Size of Tumors in Resected Pulmonary Adenocarcinoma with a Size of 30 mm or Smaller
por: Seok, Yangki, et al.
Publicado: (2014)

Video-assisted thoracic surgery sleeve resection and bronchoplasty using 3D imaging system: its safety and efficacy
por: Seong, Yong Won, et al.
Publicado: (2021)

Prognostic Implications of Postoperative Infectious Complications in Non-Small Cell Lung Cancer
por: Jang, Hyo-Jun, et al.
Publicado: (2018)

Evaluate the outcome of pneumonectomy for stage III a-N2 NSCLC
por: Park, Sungjoon, et al.
Publicado: (2015)

Single-Port Video-Assisted Thoracic Surgery for Secondary Spontaneous Pneumothorax: Preliminary Results
por: Kim, Min-Seok, et al.
Publicado: (2015)

Subcostal robotic-assisted pulmonary resection: Left lingular segmentectomy
por: Vishnu, Rajkamal, et al.
Publicado: (2022)

Clinical application of single incision thoracoscopic surgery: early experience of 264 cases
por: Song, In-Hag, et al.
Publicado: (2014)

Differentiating thymoma from thymic cyst in anterior mediastinal abnormalities smaller than 3 cm
por: Jung, Woohyun, et al.
Publicado: (2020)

Poor Prognosis of Grade 2 Spread Through Air Spaces in Neuroendocrine Tumors
por: Chae, Mincheol, et al.
Publicado: (2022)

Impact of idiopathic pulmonary fibrosis on recurrence after surgical treatment for stage I–III non-small cell lung cancer
por: Song, Myung Jin, et al.
Publicado: (2020)

Curative Resection for Metachronous Pulmonary Metastases from Colorectal Cancer: Analysis of Survival Rates and Prognostic Factors
por: Ihn, Myong Hoon, et al.
Publicado: (2017)

Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB–IIA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2022)

Prognostic Significance of the Extranodal Extension of Regional Lymph Nodes in Stage III-N2 Non-Small-Cell Lung Cancer after Curative Resection
por: Shih, Beatrice Chia-Hui, et al.
Publicado: (2021)

Impact of Statin Use on Recurrence or Survival After Surgical Curative Resection of Non-Small Cell Lung Cancer
por: Oh, Tak Kyu, et al.
Publicado: (2018)

Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non‐predominant lung adenocarcinoma
por: Cao, Shuhui, et al.
Publicado: (2018)

Surgical resection of nodular ground-glass opacities without percutaneous needle aspiration or biopsy
por: Cho, Jaeyoung, et al.
Publicado: (2014)

Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2017)

Role of prognostic nutritional index in postoperative radiotherapy for non‐small cell lung cancer
por: Ryu, Hyejo, et al.
Publicado: (2023)

MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status
por: Kim, Hyojin, et al.
Publicado: (2016)

Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer
por: Kim, Miso, et al.
Publicado: (2014)

A novel nomogram for identifying candidates for adjuvant chemotherapy in patients with stage IB gastric adenocarcinoma
por: Xie, Yangyang, et al.
Publicado: (2023)

Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity‐matched analysis in a cohort of 147 recurrences
por: Xu, Fei, et al.
Publicado: (2022)

Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial
por: Park, Cheol-Kyu, et al.
Publicado: (2022)

Cost-effectiveness analysis of adjuvant therapy with atezolizumab in Chinese patients with stage IB-IIIA resectable NSCLC after adjuvant chemotherapy
por: Chen, Ping, et al.
Publicado: (2022)

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma
por: Lee, Po-Hsin, et al.
Publicado: (2023)

Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma
por: Park, Eunhyang, et al.
Publicado: (2016)

Impact on Survival on Interval between Surgery and Adjuvant Chemotherapy in Completely Resected Stage IB-IIIA Lung Cancer
por: Wang, Bing-Yen, et al.
Publicado: (2016)

Adjuvant Chemotherapy for the Completely Resected Stage IB Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: He, Jiaxi, et al.
Publicado: (2015)

Surgery for Pulmonary Sclerosing Hemangioma: Lobectomy versus Limited Resection
por: Park, Joon Seok, et al.
Publicado: (2011)

The role of chemotherapy in patients with stage IB gastric adenocarcinoma: a real-world competing risk analysis
por: Xie, Yangyang, et al.
Publicado: (2022)

The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection
por: Kim, Young Saing, et al.
Publicado: (2017)

Outcome of Limited Resection for Lung Cancer
por: Cho, Jeong Su, et al.
Publicado: (2011)

Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
por: Lee, Kuan-Yu, et al.
Publicado: (2023)

Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors
por: Choi, Juwhan, et al.
Publicado: (2022)

Deconstructing ADAURA: It is Time to Forgo Adjuvant Platinum-Based Chemotherapy in Resected IB-IIIA EGFR+ NSCLC (Except with RB Alterations?) When Adopting Adjuvant Osimertinib
por: Zhang, Shannon S, et al.
Publicado: (2022)

Role of adjuvant treatment in stage IB non-small cell lung carcinoma
por: Park, Cheol-Kyu, et al.
Publicado: (2023)

Long-Term Oncologic Outcomes for Patients Undergoing Volatile Versus Intravenous Anesthesia for Non-Small Cell Lung Cancer Surgery: A Retrospective Propensity Matching Analysis
por: Oh, Tak Kyu, et al.
Publicado: (2018)

Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer
por: Park, Seong Yong, et al.
Publicado: (2013)

Deconstructing ADAURA. It is Not Yet Time to Forgo Platinum-based Adjuvant Chemotherapy in Resected Early Stage (IB-IIIA) EGFR-mutant NSCLC
por: Brazel, Danielle, et al.
Publicado: (2022)

Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III Trial
por: Kim, Youjin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gola5r6fbtrs3t4e58h118232f